Skip to content

Collegium Pharmaceutical, Inc. COLL Other Non-Current Assets

Other Non-Current Assets at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$26M-33.3%
Avanos Medical logo
Avanos MedicalAVNS
$32.9M+29.5%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$56.45M+93.2%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$25.3M+83.0%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.93M+170%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+17.9%
Enterprise value$869.67M-0.3%
P/E15.4×-6.9×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s other non-current assets?
Collegium Pharmaceutical, Inc. (COLL) reported other non-current assets of $16.06M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s other non-current assets changed year-over-year?
Collegium Pharmaceutical, Inc.'s other non-current assets increased by 218.9% year-over-year, from $5.04M to $16.06M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s other non-current assets has grown at a 177.4% compound annual growth rate (CAGR), from $123K to $20.19M.
What does other non-current assets mean?
This category captures long-term assets that do not fit into standard classifications like property, plant, equipment, or intangible assets. It may include long-term deposits, deferred tax assets, or other miscellaneous non-current investments. It represents the residual value of long-term resources held by the company.